Literature DB >> 10971892

Phase I cancer trials. A collusion of misunderstanding.

M Miller.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2000        PMID： 10971892

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN： 0093-0334            Impact factor:   2.683


× No keyword cloud information.
  31 in total

1.  Strategies to minimize risks and exploitation in phase one trials on healthy subjects.

Authors:  Adil E Shamoo; David B Resnik
Journal:  Am J Bioeth       Date:  2006 May-Jun       Impact factor: 11.229

2.  Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis.

Authors:  J Kimmelman; N Palmour
Journal:  J Med Ethics       Date:  2005-04       Impact factor: 2.903

3.  Phase I oncology trials: why the therapeutic misconception will not go away.

Authors:  W Glannon
Journal:  J Med Ethics       Date:  2006-05       Impact factor: 2.903

4.  The myth of equipoise in phase 1 clinical trials.

Authors:  Adil E Shamoo
Journal:  Medscape J Med       Date:  2008-11-05

5.  Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study.

Authors:  Stacey L Berg; Naomi Winick; Ashish Mark Ingle; Peter C Adamson; Susan M Blaney
Journal:  Pediatr Blood Cancer       Date:  2010-07-15       Impact factor: 3.167

6.  Adolescent perspectives on phase I cancer research.

Authors:  Victoria A Miller; Justin N Baker; Angela C Leek; Sabahat Hizlan; Susan R Rheingold; Amy D Yamokoski; Dennis Drotar; Eric Kodish
Journal:  Pediatr Blood Cancer       Date:  2012-10-03       Impact factor: 3.167

7.  Expression of therapeutic misconception amongst Egyptians: a qualitative pilot study.

Authors:  Mayyada Wazaify; Susan S Khalil; Henry J Silverman
Journal:  BMC Med Ethics       Date:  2009-06-30       Impact factor: 2.652

8.  Communicating and understanding the purpose of pediatric phase I cancer trials.

Authors:  Melissa K Cousino; Stephen J Zyzanski; Amy D Yamokoski; Rebecca A Hazen; Justin N Baker; Robert B Noll; Susan R Rheingold; J Russell Geyer; Stewart C Alexander; Dennis Drotar; Eric D Kodish
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

9.  Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?

Authors:  Nancy Kass; Holly Taylor; Linda Fogarty; Jeremy Sugarman; Steven N Goodman; Annallys Goodwin-Landher; Michael Carducci; Herbert Hurwitz
Journal:  J Empir Res Hum Res Ethics       Date:  2008-09       Impact factor: 1.742

Review 10.  The clinical investigator-subject relationship: a contextual approach.

Authors:  David B Resnik
Journal:  Philos Ethics Humanit Med       Date:  2009-12-03       Impact factor: 2.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.